↓ Skip to main content

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

Overview of attention for article published in BMC Neurology, August 2008
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
245 Dimensions

Readers on

mendeley
183 Mendeley
citeulike
4 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials
Published in
BMC Neurology, August 2008
DOI 10.1186/1471-2377-8-29
Pubmed ID
Authors

Asquad Sultan, Helen Gaskell, Sheena Derry, R Andrew Moore

Abstract

Duloxetine hydrochloride is a reuptake inhibitor of 5-hydroxytryptamine and norepinephrine used to treat depression, generalized anxiety disorder, neuropathic pain, and stress incontinence in women. We investigated the efficacy of duloxetine in painful diabetic neuropathy and fibromyalgia to allow comparison with other antidepressants.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 2 1%
Spain 2 1%
Australia 1 <1%
India 1 <1%
United States 1 <1%
Unknown 176 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 16%
Student > Ph. D. Student 19 10%
Student > Master 18 10%
Other 16 9%
Student > Bachelor 16 9%
Other 49 27%
Unknown 36 20%
Readers by discipline Count As %
Medicine and Dentistry 72 39%
Agricultural and Biological Sciences 13 7%
Psychology 13 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Nursing and Health Professions 8 4%
Other 31 17%
Unknown 37 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2020.
All research outputs
#7,452,489
of 22,783,848 outputs
Outputs from BMC Neurology
#844
of 2,430 outputs
Outputs of similar age
#28,991
of 82,260 outputs
Outputs of similar age from BMC Neurology
#3
of 7 outputs
Altmetric has tracked 22,783,848 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,430 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,260 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.